Ewa A. Kalinka

Lodz, LD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

HPA axis function during adjunctive high-dose dexamethasone use in chemotherapy: a prospective pilot study.

HPA axis function during adjunctive high-dose dexamethasone use in chemotherapy: a prospective pilot study.

Journal: Frontiers in endocrinology

Published: February 12, 2026

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.

Journal: Cancers

Published: January 19, 2026

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial.

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 16, 2025

Isolated secondary adrenal failure accompanied by primary hypothyroidism after treatment with nivolumab and ipilimumab for kidney cancer.

Isolated secondary adrenal failure accompanied by primary hypothyroidism after treatment with nivolumab and ipilimumab for kidney cancer.

Journal: Endokrynologia Polska

Published: October 25, 2025

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Journal: Breast (Edinburgh, Scotland)

Published: October 12, 2025

Evaluating the Utility of Fresh Tissue in Molecular Diagnostics of Colorectal Cancer.

Evaluating the Utility of Fresh Tissue in Molecular Diagnostics of Colorectal Cancer.

Journal: Cancers

Published: September 16, 2025

Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer.

Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer.

Journal: Przeglad menopauzalny = Menopause review

Published: August 24, 2025

First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials.

First-Line Cemiplimab for Locally Advanced NSCLC: Updated Subgroup Analyses From the EMPOWER-Lung 1 and EMPOWER-Lung 3 Trials.

Journal: JTO clinical and research reports

Published: July 14, 2025

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Journal: ImmunoTargets and therapy

Published: June 20, 2025

Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.

Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.

Journal: Scientific reports

Published: March 31, 2025

Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene.

Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene.

Journal: Cancers

Published: October 30, 2024

Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.

Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.

Journal: Therapeutic advances in medical oncology

Published: October 08, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026